RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2020

Jun 18, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2020-06-17

Reporting Person: JEAN CHRISTOPHE (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-17	Stock Option (right to buy)	$21.37	A	18500	Acquired	2030-06-16	Common Stock (18500)	Direct

Footnotes

F1: The options fully vest upon the earlier of (i) 1 year from the date of grant or (ii) the date of the Issuer's next annual meeting of the stockholders.